As of 2026-11-04 09:48 UTC.Market figures are as the cited sources reported them at that time and may have moved since. This is news, not investment advice.
Neurocrine Biosciences rose 15.1% and Regal Rexnord Corporation rose 11.5% in afternoon trading following their third quarter 2026 earnings releases. [1][2]